Professional Associations

This page includes news coverage of medical associations and medical societies. Use these links to find focused news coverage from specific organizations: Cardiology Associations, Healthcare Associations, Radiology Associations.

TAVR a safe treatment option for patients who have undergone chest radiation therapy
In fact, researchers wrote, TAVR and SAVR were linked to comparable long-term outcomes for heart patients who have previously been exposed to mediastinal radiation.
ASE promoting 3D echo as a better way to treat congenital heart disease
The introduction of a 3D pediatric transesophegeal echo probe is having a major impact on how these pediatric congenital heart patients are being treated.
FDA approves new Biotronik pacing lead for LBBAP
The next-generation device includes a stylet-driven lead and a fixed helix. It was designed and developed specifically with LBBAP in mind.
Registry data point to ‘striking shift’ in treatment decisions after FDA approved low-risk TAVR
Many experts still recommend SAVR over TAVR for patients younger than 65 years old with severe aortic stenosis. However, transcatheter treatments are growing more and more popular when these younger patients require a valve replacement.
Cardiologist says new legislation would delay flawed payment cuts, preserve access to care
The efficiency adjustment cuts introduced in the 2026 MPFS are based on assumptions many doctors believe to be false. The American Society of Nuclear Cardiology and other medical societies are pushing back.

money cost cutting Medicare scissors dollar economics

Cardiology, cardiac imaging groups support new bill delaying cuts to physician pay

Nearly 40 healthcare organizations signed a letter in support of the bipartisan legislation, noting that Medicare's “efficiency adjustment” decreases reimbursement during a challenging time for physicians.

AI-powered MRI evaluations predict STEMI outcomes better than existing risk scores

Researchers found that their advanced machine learning model consistently outperformed current risk stratification techniques.

Medtronic's Evolut Pro TAVR valve treating aortic stenosis

TAVR linked to higher reintervention rate than SAVR in Evolut Low Risk trial update

The Evolut Low Risk trial has been one of cardiology’s most closely watched studies for years now. For the first five years after treatment, TAVR and SAVR were associated with comparable outcomes when treating low-risk patients. In this new six-year update, however, TAVR was linked to a heightened risk of reintervention not seen with SAVR.

Bayer: Aiding Customer Resilience Amid CT Disruption

Sponsored by Bayer

U.S. Radiology departments navigating CT market challenges—supply disruptions and rising demand for contrast and delivery—need reliable partners. Hear Bayer leads explain how Bayer helps provide steady supply and innovations to support CT imaging and patient care.

Rich Fabian, Medical Imaging Technology at AdvaMed Imaging chair of board, a medtech industry group made up of medical imaging companies to address higher level public policy concerns, explains key reimbursement issues impacting medical imaging.

Imaging industry group concerned about paltry insurance payment rates

Chairman Rich Fabian says AdvaMed Imaging is concerned about low Medicare pay rates and onerous rules created by private insurers.

$iad Ali, MD, DPhil, director of the DeMatteis Cardiovascular Institute and director investigational interventional cardiology, St. Francis Hospital and Heart Center, explains how coronary computed tomography angiography (CCTA) offers a shift in cardiac care and interventional cardiology because of the information it offers on plaque burden and ischemia based on fractional flow reserve CT (FFR-CT). #TCT #YesCCT$

CCTA becoming an essential tool for interventional cardiologists

Ziad Ali, MD, explains how coronary computed tomography angiography is creating a major shift in cardiac care.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Cardiologists propose new 'coronary risk zone' approach for redo TAVR planning

Redo TAVR can be challenging, requiring a significant amount of preprocedural CT planning. This proposed framework was designed to simplify that planning and help interventional cardiologists thrive.

CCTA delivers value, even when treating low-risk patients with no history of CAD

Total plaque volume and total plaque burden can help find patients who may be closer to suffering a heart attack than they realize.

Professional Associations

TAVR a safe treatment option for patients who have undergone chest radiation therapy

ASE promoting 3D echo as a better way to treat congenital heart disease

FDA approves new Biotronik pacing lead for LBBAP

Registry data point to ‘striking shift’ in treatment decisions after FDA approved low-risk TAVR

Cardiologist says new legislation would delay flawed payment cuts, preserve access to care